Intellectual property financing and enterprise growth

Chen He, Yinliang Zhang and Na Wang

Finance Research Letters, 2025, vol. 77, issue C

Abstract: Using data from Chinese pharmaceutical companies listed between 2003 and 2022 and employing quantitative analysis, this study explores the relationship between intellectual property (IP) financing, corporate turnover capabilities, and enterprise growth. This study reveals that IP financing significantly enhances firms’ research and development as well as market competitiveness, thereby promoting growth. Furthermore, this study examines how IP financing varies and interacts with various pharmaceutical companies. Findings provide theoretical support and practical guidance for pharmaceutical companies seeking to develop IP financing strategies and improve turnover capacities, offering valuable support for policy formulation. This study has important theoretical and practical implications.

Keywords: Pharmaceutical enterprises; Intellectual property financing; Enterprise growth; Corporate turnover capability (search for similar items in EconPapers)
Date: 2025
References: Add references at CitEc
Citations:

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S154461232500340X
Full text for ScienceDirect subscribers only

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:finlet:v:77:y:2025:i:c:s154461232500340x

DOI: 10.1016/j.frl.2025.107076

Access Statistics for this article

Finance Research Letters is currently edited by R. Gençay

More articles in Finance Research Letters from Elsevier
Bibliographic data for series maintained by Catherine Liu ().